SCHEMBL6945320

SCHEMBL6945320

N#CCn1c(-c2nccnc2-c2ccccc2N)nc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
ALDH1A1 P00352 5/20 0.40
PRKACA P17612 3/20 0.39
RPS6KB1 P23443 3/20 0.39
GSK3B P49841 3/20 0.39
ROCK1 Q13464 3/20 0.39
RPS6KA5 O75582 2/20 0.39
KDM4E B2RXH2 5/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNK13 Q9HB14 1/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12676401 0.86 ALDH1A1 (0.46) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1901248 0.85 RPS6KA5 (0.50) MAPTALDH1A1PRKACARPS6KB1GSK3B
SCHEMBL15235359 0.81 ALDH1A1 (0.45) ALDH1A1PRKACARPS6KB1GSK3BROCK1
SCHEMBL14390002 0.79 RPS6KA5 (0.53) MAPTALDH1A1RPS6KA5KDM4EMEN1
SCHEMBL14364662 0.77 ALDH1A1 (0.42) MAPTALDH1A1PRKACARPS6KB1GSK3B
SCHEMBL1901563 0.77 ALDH1A1 (0.43) MAPTALDH1A1PRKACARPS6KB1GSK3B
SCHEMBL6945316 0.75 GAA (0.42) MAPTALDH1A1GSK3BKDM4EMEN1
SCHEMBL1898594 0.75 KDM4E (0.46) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1898102 0.74 RPS6KB1 (0.70) MAPTALDH1A1PRKACARPS6KB1GSK3B
SCHEMBL14364664 0.70 ALDH1A1 (0.43) ALDH1A1PRKACARPS6KB1GSK3BROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040034037-A1 Heteroaryl compounds useful as inhibitors of GSK-3 VERTEX PHARMACEUTICALS, INCORPORATED 2004-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034037-A1 Heteroaryl compounds useful as inhibitors of GSK-3 GSK3B, GSK3A, GSKIP MAPT 256/4885ALDH1A1 3514/4885PRKACA 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.